Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT

Diagnoses Disease Clinical Trial

Official title:

Usefulness of Low kVp High mAs Computed Tomography for the Evaluation of Pancreatic Cancer Resectability

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03895177
• Other study ID #: SNUH-2019-0140
• Status: Active, not recruiting
• Phase: N/A
• Start date: March 12, 2019
• Est. completion date: January 31, 2022

Study information

• Verified date: March 2021
• Source: Seoul National University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to investigate usefulness of low kVp high mAs computed tomography in evaluation of pancreatic cancer resectability.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 147
• Est. completion date: January 31, 2022
• Est. primary completion date: October 28, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 85 Years

Eligibility

Inclusion Criteria:

• 1. age between 20 year-old and 85 year-old 2. patient with pancreatic cancer detected on standard CT scan using 120 kVp that obtained within one month 3. consider surgical resection for pancreatic cancer treatment 4. patients who can undergo contrast enhanced CT scan

Exclusion Criteria:

• 1. history of severe adverse reaction to iodine contrast 2. less than 60 of estimated GFR

Related Conditions & MeSH terms

• Diagnoses Disease

Intervention

Diagnostic Test:
• contrast enhanced computed tomography
pancreatic protocol CT with 80kVp tube voltage and more than 500mA tube current acquire late arterial phase and portal venous phase using volus tracking method

Locations

Country	Name	City	State
Korea, Republic of	Hallym University Sacred Heart Hospital	Anyang
Korea, Republic of	Korea National Cancer Center	Goyang-si	Kyung-gi Do
Korea, Republic of	Asan medical Center	Seoul
Korea, Republic of	Korea University Guro Hospital	Seoul
Korea, Republic of	Seoul National University Hospital	Seoul
Korea, Republic of	Severance Hospital	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	accuracy of low kVp CT to assess R0 resection of pancreatic cancer	Pancreastic cancer resectability	2 weeks after surgery